Difference between revisions of "Team:Paris Bettencourt/Active Testing"

Line 45: Line 45:
  
 
<div class='textbody'>
 
<div class='textbody'>
−
<p> We quantified StarCore activity by determining their minimum inhibitory concentrations (MIC). We also evaluated their impact on bacterial growth by treating bacterial cultures with varying concentrations of StarCores and monitoring the OD600 through time. Representative results are shown in Figure 1. As a control, we also determined the MIC of Ovispirin, a commonly used AMP with no star-shaped geometry. </p>
+
<p> We evaluated the impact of StarCores on bacterial growth by treating bacterial cultures with the fusion proteins and monitoring the OD 600 through time. Representative results are shown in Fig. 1. </p>
−
<p> StarCores displayed a range of MICs, generally similar to control values. The top performing StarCore was the Ferritin-Alyteserin fusion, with an activity almost 10 times higher than that of the control.</p>
+
 
</div>
 
</div>
  
 
<div class="text3 img">
 
<div class="text3 img">
−
<img src="https://static.igem.org/mediawiki/2018/5/5c/T--Paris_Bettencourt--_GC_Ecoli_A.png">
+
<img src="https://2018.igem.org/File:T--Paris_Bettencourt--_GC_Ecoli_A_2.png">
−
<img src="https://static.igem.org/mediawiki/2018/c/c6/T--Paris_Bettencourt--TGC_Bsub_B.png">
+
<img src="https://static.igem.org/mediawiki/2018/8/81/T--Paris_Bettencourt--_GC_Bsub_B_2.png">
 
</div>
 
</div>
  
−
<div class='textbody h3'>
+
<div class='textbody'>
−
<h3><b> StarCores vary in species specificity </b></h3>
+
<p> Fig. 1. Growth curves of <i>E. coli </i>(A) and <i>B. subtilis </i>(B) in the presence of StarCores. </p>
 
</div>
 
</div>
  
 
<div class='textbody'>
 
<div class='textbody'>
−
<p> We performed MIC determinations for both <i>E. coli</i>, a Gram-negative bacterium and <i>B. subtilis</i>, a Gram-positive strain. In general, StarCores displayed higher antimicrobial activities than the control Ovispirin in <i>E. coli</i>. While some StarCores exhibited a higher activity towards one bacterial class, others were largely nonspecific. </p>
+
<p> We also quantified their antimicrobial activity by determining the minimum inhibitory concentrations (MIC). Ovispirin, a commonly used antimicrobial peptide (AMP) with no star-shaped geometry, was used as a control in every experiment. The results of the MIC determination are summarized in Table 1. </p>
−
<p> Differences in StarCore activity may be attributed to differences in membrane lipid charge and electrostatic potential, which vary among species and are believed to mediate AMP-membrane interactions. This idea is explored in more detail in the modelling and optimization sections. </p>
+
 
</div>
 
</div>
  
−
<div class='textbody h3'>
+
<div class="text3 img">
−
<h3><b> StarCore activity is relatively unaffected by geometry </b></h3>
+
<img src=" https://static.igem.org/mediawiki/2018/6/69/T--Paris_Bettencourt--_Table_MIC2.png">
 
</div>
 
</div>
  
−
<div class='textbody'>
 
−
<p> In order to investigate the influence of the architecture and the composition of the StarCores on their antimicrobial efficiency, we compared the MIC of constructs containing the same core but different AMPs (Fig X a) and that of constructs containing the same AMPs but different cores (Fig X b).
 
−
</p>
 
−
<p> Differences in StarCore activity may be attributed to differences in membrane lipid charge and electrostatic potential, which vary among species and are believed to mediate AMP-membrane interactions. This idea is explored in more detail in the modelling and optimization sections. </p>
 
−
</div>
 
  
 
</body>
 
</body>
 
</html>
 
</html>
 
{{Paris_Bettencourt/Templatesbottom}}
 
{{Paris_Bettencourt/Templatesbottom}}

Revision as of 13:39, 6 December 2018


Active Testing

Following the production phase of our project, we had 10 StarCore constructs to test. We set out to characterize their antimicrobial properties and mechanism of action. We had many questions in the following categories.

  • Antimicrobial activity: Do they kill bacteria? What is their effective concentration?

  • Specificity: Do they selectively kill certain types of bacteria?

  • Mechanism of action: How do they kill the bacteria?

  • Toxicity: How toxic are they to human cells?

  • Geometry: Does the structure of a StarCore change the function?

    • Results

    StarCores kill bacteria at micromolar concentrations

    We evaluated the impact of StarCores on bacterial growth by treating bacterial cultures with the fusion proteins and monitoring the OD 600 through time. Representative results are shown in Fig. 1.

    Fig. 1. Growth curves of E. coli (A) and B. subtilis (B) in the presence of StarCores.

    We also quantified their antimicrobial activity by determining the minimum inhibitory concentrations (MIC). Ovispirin, a commonly used antimicrobial peptide (AMP) with no star-shaped geometry, was used as a control in every experiment. The results of the MIC determination are summarized in Table 1.

    Centre for Research and Interdisciplinarity (CRI)
    Faculty of Medicine Cochin Port-Royal, South wing, 2nd floor
    Paris Descartes University
    24, rue du Faubourg Saint Jacques
    75014 Paris, France
    paris-bettencourt-2018@cri-paris.org